NSETrading Window28 Sept 2026 · 28 Sept 2026, 01:00 pm
Trading Window
Dr. Agarwal's Health Care Limited · AGARWALEYE
✦ AI SummaryResults
Dr. Agarwal's Health Care Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, due to the finalization and publication of the Unaudited Financial Results for the quarter and half year ending September 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Dr. Agarwal's Health Care Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
DRAGARWALS_28092026130020_AHCL_TW_CLOSURE_SE.pdf
View document text
Ref: AHCL/2026-27/C042 September 28, 2026
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No C/1, “G” Block,
Dalal Street, Bandra-Kurla Complex
Mumbai – 400 001 Bandra (E), Mumbai – 400 051
Scrip Code: 544350 Symbol: AGARWALEYE
Dear Sir / Madam,
Sub: Closure of Trading Window
This is to inform that pursuant to Dr. Agarwal’s Health Care Limited (‘the Company’) Code of
Conduct for Prevention of Insider Trading, the Trading Window for dealing in the securities
of the Company shall remain closed for all the Designated Persons and their Immediate
Relatives with effect from September 30, 2026.
The Trading Window closure is being implemented in view of the finalization and publication
of the Unaudited Financial Results (Standalone and Consolidated) of the Company for the
quarter and half year ending September 30, 2026.
The Trading Window shall reopen after the expiry of 48 hours from the announcement of the
aforesaid Financial Results by the Company, duly approved by the Board of Directors at their
meeting, the details of which shall be communicated in the due course.
This information can also be accessed on the website of the Company at:
www.dragarwals.co.in
We request you to kindly take the above on record.
Thanking you,
For Dr. Agarwal’s Health Care Limited
Thanikainathan Arumugam
Company Secretary and Compliance Officer